Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Trobisch, A; Marterer, R; Gorkiewicz, G; Flaschberger, S; Lackner, H; Seidel, M; Sperl, D; Karastaneva, A; Kohlmaier, B; Egger, M; Urban, C; Benesch, M; Strenger, V.
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
Support Care Cancer. 2020; 28(5):2157-2161 Doi: 10.1007/s00520-019-04962-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Strenger Volker
Trobisch Andreas
Co-Autor*innen der Med Uni Graz
Benesch Martin
Egger Markus
Gorkiewicz Gregor
Karastaneva Anna
Kohlmaier Benno
Lackner Herwig
Marterer Robert
Seidel Markus
Sperl Daniela Ingrid
Urban Ernst-Christian

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

A 5-year-old patient treated for acute lymphoblastic leukaemia (ALL) developed proven pulmonary invasive fungal disease (IFD) due to Actinomucor elegans. While completing ALL treatment according to AIEOP ALL protocol 2009 for further 15 months, antifungal treatment with liposomal amphotericin B and intermittent additional posaconazole was continued until immune reconstitution 7 months after the end of ALL treatment. Repeated imaging guided treatment decisions. Twenty-six and 19 months after the end of ALL treatment and antifungal treatment, respectively, the patient is still in the first complete remission and shows no signs of active invasive fungal disease (IFD).

Find related publications in this database (Keywords)
Antimycotic treatment
© Med Uni Graz Impressum